GlobeNewswire Inc.··NaScilex Subsidiaries Sell ACEA Pharma to Phoenix Asia in $1B Share Deal
Scilex subsidiaries sell ACEA Pharma to Phoenix Asia for $1B in stock; retain 82% ownership post-Nasdaq listing in Q2 2026.
SCLXSCLXWPHOEpharmaceutical companyNasdaq listing